China’s Disposable Syringes Face Antidumping Investigation In Brazil
This article was originally published in PharmAsia News
According to China Chamber of Commerce of Medicines & Health Products Importers & Exporters, a Brazilian corporation has applied for an antidumping investigation on China-made disposable plastic syringes. Currently, Brazil ranks as China's third largest export destination, with 340 million disposable syringes worth $91.7 million sold to Brazil in 2007. Industry figures show that China's 3 billion yuan disposable medical devices market is shared by more than 300 corporations. Excessive domestic competition has pushed more disposable medical device makers to sell their products at very low price overseas. The battle for market share and razor-thin profit margins have created a vicious cycle for these suppliers and the latest antidumping action represents another blow to the industry. (Click here for more - Chinese Language)
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.